A phase I / II trial of intraperitoneal paclitaxel and carboplatin after cytoreductive surgery for the treatment of patients with ovarian carcinoma with peritoneal carcinosis or primary peritoneal carcinomatosis. En fase I / II forsog med intraperitoneal Paclitaxel og Carboplatin efter cytoreduktiv operation som behandling af Patienter med ovarie carcinoma med peritoneal carcinose eller primaer peritoneal carcinomatose
Latest Information Update: 10 Dec 2012
Price :
$35 *
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Dec 2012 New trial record